Gilead Sciences | GILD - Kreditur Perdagangan

Harga Saham
130.84
Perubahan Harian
2.00 1.55%
Bulanan
-6.12%
Tahunan
26.72%
Q2 Perkiraan
127.61




Kreditur Perdagangan Perubahan Tanggal
AbbVie USD 3.59B 28.65B 2025-12
Agios Pharmaceuticals USD 13.75M 4.61M 2026-03
ALKERMES USD 107.95M 39.95M 2025-12
Alnylam Pharmaceuticals USD 126.63M 10.91M 2026-03
Amgen USD 20.89B 1.25B 2025-12
Biogen USD 358.5M 73.5M 2026-03
BioMarin Pharmaceutical USD 759.03M 39.41M 2025-12
Bristol-Myers Squibb USD 4.23B 659M 2026-03
Coherus Biosciences USD 9.91M 14.98M 2025-12
Eli Lilly USD 5.03B 350M 2026-03
Gilead Sciences USD 715M 93M 2025-12
GlaxoSmithKline GBP 14.34B 1.05B 2026-03
Glaxosmithkline GBP 20.72B 346.14M 2025-12
Incyte USD 228.62M 1.41B 2026-03
J&J USD 10.46B 1.53B 2026-03
Merck USD 4.4B 257M 2025-12
Moderna USD 317M 50M 2025-12
Neurocrine Biosciences USD 545.5M 425.6M 2025-12
Novartis USD 4.46B 99M 2025-12
Pfizer USD 5.02B 142M 2025-09
PTC Therapeutics USD 45.49M 8.87M 2025-12
Puma Biotechnology USD 6.39M 962K 2025-09
Regeneron Pharmaceuticals USD 1.03B 4.81B 2026-03
Sangamo BioSciences USD 10.74M 7.46M 2025-06
Sanofi EUR 22.71B 219M 2026-03
Sarepta Therapeutics USD 280.84M 186.83M 2025-12
United Therapeutics USD 7.1M 460.9M 2025-12
Vertex Pharmaceuticals USD 3.43B 600.9M 2025-12